Fauci Outlines Ambitious Plan to Scale Up Covid-19 Vaccine

March 27, 2020, 12:06 AM UTC

A Covid-19 vaccine will go into production while researchers are still studying if it works, under an ambitious plan by NIH’s Anthony S. Fauci to get a vaccine across the finish line in record time.

The proposal to start ramping up production while the candidate is still in a clinical trial is a risky step for a manufacturer, which would have to start assembling raw materials to make a vaccine without knowing whether it would work.

But the plan would make sure a vaccine is ready for patients if Covid-19, the disease caused by the new coronavirus, comes back next ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.